Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 992.00M | 969.00M | 950.00M | 897.00M | 871.00M |
| Total Depreciation and Amortization | 570.00M | 560.00M | 543.00M | 517.00M | 493.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 274.00M | 337.00M | 229.00M | 185.00M | 171.00M |
| Change in Net Operating Assets | 50.00M | 19.00M | -44.00M | -105.00M | -201.00M |
| Cash from Operations | 1.89B | 1.89B | 1.68B | 1.49B | 1.33B |
| Capital Expenditure | -527.00M | -492.00M | -454.00M | -438.00M | -425.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -101.00M | -434.00M | -1.93B | -2.02B | -2.16B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.00M | -16.00M | 13.00M | 10.00M | 41.00M |
| Cash from Investing | -631.00M | -942.00M | -2.37B | -2.45B | -2.55B |
| Total Debt Issued | 410.00M | 410.00M | 2.25B | 2.06B | 1.85B |
| Total Debt Repaid | -1.01B | -1.01B | -1.00B | -903.00M | -303.00M |
| Issuance of Common Stock | 79.00M | 82.00M | 87.00M | 90.00M | 73.00M |
| Repurchase of Common Stock | -495.00M | -345.00M | -194.00M | -194.00M | -175.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -353.00M | -347.00M | -342.00M | -336.00M | -331.00M |
| Other Financing Activities | -17.00M | -59.00M | -48.00M | -42.00M | -26.00M |
| Cash from Financing | -1.39B | -1.27B | 746.00M | 676.00M | 1.08B |
| Foreign Exchange rate Adjustments | 4.00M | -4.00M | -2.00M | -6.00M | -7.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -129.00M | -332.00M | 48.00M | -286.00M | -137.00M |